Stryker Corp.

SYK-N

NYSE:SYK

245.21
3.14 (1.30%)
Stryker Corporation is a Fortune 500 medical technologies firm based in Kalamazoo, Michigan. Stryker's products include implants used in joint replacement and trauma surgeries; surgical equipment and ...
More at Wikipedia

Analysis and Opinions about SYK-N

Signal
Opinion
Expert
TOP PICK
TOP PICK
August 21, 2017

Comparing them to JNJ-N, SYK-N is blowing them out of the water. They are doing 3D printers to create products where bone can grow back. Dividend growth is in the 20% range. (Analysts’ target: US$156.00).

Show full opinionHide full opinion
Stryker Corp. (SYK-N)
August 21, 2017

Comparing them to JNJ-N, SYK-N is blowing them out of the water. They are doing 3D printers to create products where bone can grow back. Dividend growth is in the 20% range. (Analysts’ target: US$156.00).

COMMENT
COMMENT
May 9, 2017

The medical device space has done well in healthcare. This goes back to so much money having left biotech. Part of what drives this one is surgical procedure growth. As the population ages, you need to get more surgical procedures. There are some good trends behind this company and it has been executing well. (See Top Picks.)

Show full opinionHide full opinion

The medical device space has done well in healthcare. This goes back to so much money having left biotech. Part of what drives this one is surgical procedure growth. As the population ages, you need to get more surgical procedures. There are some good trends behind this company and it has been executing well. (See Top Picks.)

TOP PICK
TOP PICK
March 16, 2017

This is known for knees and hips, and they have sold millions of knee replacement implants. They’ve recently started using a robot to replace the body parts, giving greater accuracy and lower costs. With the robot, you can only use their parts, making it a closed system. He doesn’t foresee any changes in the US health care act having an effect on this company and their equipment. Dividend yield of 1.3%. (Analysts’ price target is $132.)

Show full opinionHide full opinion
Stryker Corp. (SYK-N)
March 16, 2017

This is known for knees and hips, and they have sold millions of knee replacement implants. They’ve recently started using a robot to replace the body parts, giving greater accuracy and lower costs. With the robot, you can only use their parts, making it a closed system. He doesn’t foresee any changes in the US health care act having an effect on this company and their equipment. Dividend yield of 1.3%. (Analysts’ price target is $132.)

BUY
BUY
March 1, 2017

This is a business that people need to have exposure to. His clients own a similar company, Zimmer Biomet (ZBH-N) which manufactures replacements for hips, knees, and they do stuff for your back, dental. This is a business that unfortunately is going to do well as people age and live longer and wear out their useful parts. Hips and knee replacements is going to grow at a significant rate, and there are only a few companies that manufacture these things.

Show full opinionHide full opinion
Stryker Corp. (SYK-N)
March 1, 2017

This is a business that people need to have exposure to. His clients own a similar company, Zimmer Biomet (ZBH-N) which manufactures replacements for hips, knees, and they do stuff for your back, dental. This is a business that unfortunately is going to do well as people age and live longer and wear out their useful parts. Hips and knee replacements is going to grow at a significant rate, and there are only a few companies that manufacture these things.

DON'T BUY
DON'T BUY
February 27, 2017

It is an interesting space, but expensive. Wait until we get clarity on what is happening with Obamacare. Investors may migrate out of the devices group.

Show full opinionHide full opinion
Stryker Corp. (SYK-N)
February 27, 2017

It is an interesting space, but expensive. Wait until we get clarity on what is happening with Obamacare. Investors may migrate out of the devices group.

BUY
BUY
February 22, 2017

This is a long-term Hold. He recently added to his holdings. This is your hip, knees, ankles, feet, prosthetics. You are paying a little bit more for their growth. This is going to be the wave of the future. Feels they are capturing market share.

Show full opinionHide full opinion
Stryker Corp. (SYK-N)
February 22, 2017

This is a long-term Hold. He recently added to his holdings. This is your hip, knees, ankles, feet, prosthetics. You are paying a little bit more for their growth. This is going to be the wave of the future. Feels they are capturing market share.

PAST TOP PICK
PAST TOP PICK
January 12, 2017

(Top Pick Feb 25/16, Up 21.75%) He is not chasing high flying pharma, but the more steady, boring ones that people use more and more as they age. They grow by acquisition.

Show full opinionHide full opinion
Stryker Corp. (SYK-N)
January 12, 2017

(Top Pick Feb 25/16, Up 21.75%) He is not chasing high flying pharma, but the more steady, boring ones that people use more and more as they age. They grow by acquisition.

DON'T BUY
DON'T BUY
November 15, 2016

When it comes to healthcare stocks, you have to differentiate between those pharmaceuticals that have very good margins without any threat to their profit margins, and a stock like this that makes implants. In the field of implants, there has been very little innovation in the last 10 years, and he thinks problems are going to come from both Medicare and Medicaid. Thinks they are going to be pushing prices down, not up, which is a threat to the implant manufacturers.

Show full opinionHide full opinion
Stryker Corp. (SYK-N)
November 15, 2016

When it comes to healthcare stocks, you have to differentiate between those pharmaceuticals that have very good margins without any threat to their profit margins, and a stock like this that makes implants. In the field of implants, there has been very little innovation in the last 10 years, and he thinks problems are going to come from both Medicare and Medicaid. Thinks they are going to be pushing prices down, not up, which is a threat to the implant manufacturers.

PAST TOP PICK
PAST TOP PICK
August 31, 2016

(A Top Pick Feb 25/16. Up 14.39%.) Hospital equipment. The growth drivers are charged by the demographics, but also having really high quality equipment, and making strategic acquisitions to integrate itself into the hospital industry structure in a better way. (Wouldn’t buy at current prices, but wait for a 10% pullback at least.)

Show full opinionHide full opinion
Stryker Corp. (SYK-N)
August 31, 2016

(A Top Pick Feb 25/16. Up 14.39%.) Hospital equipment. The growth drivers are charged by the demographics, but also having really high quality equipment, and making strategic acquisitions to integrate itself into the hospital industry structure in a better way. (Wouldn’t buy at current prices, but wait for a 10% pullback at least.)

COMMENT
COMMENT
June 21, 2016

Demographically this is really positive. Mr. Trump and Mrs. Clinton debate doesn’t factor into a company like this. They make knees and hips, and are into shoulders a bit now. They now include technology so that if a hip has problems, it can send a message. A little expensive, but a good grower and there is room for acquisitions.

Show full opinionHide full opinion
Stryker Corp. (SYK-N)
June 21, 2016

Demographically this is really positive. Mr. Trump and Mrs. Clinton debate doesn’t factor into a company like this. They make knees and hips, and are into shoulders a bit now. They now include technology so that if a hip has problems, it can send a message. A little expensive, but a good grower and there is room for acquisitions.

BUY
BUY
April 18, 2016

Thinks this is a probably going to be a good time to be investing in manufacturers of medical devices. There is a whole seasonality that starts in January with a little bit of a pickup in February. They tend to peak every year right around August/September, so there is a bit of time to ride this out.

Show full opinionHide full opinion
Stryker Corp. (SYK-N)
April 18, 2016

Thinks this is a probably going to be a good time to be investing in manufacturers of medical devices. There is a whole seasonality that starts in January with a little bit of a pickup in February. They tend to peak every year right around August/September, so there is a bit of time to ride this out.

TOP PICK
TOP PICK
February 25, 2016

Healthcare is the only sector that has both top line and earnings growth. Hospital beds, hip and knee replacements. They are geared to the aging demographic.

Show full opinionHide full opinion
Stryker Corp. (SYK-N)
February 25, 2016

Healthcare is the only sector that has both top line and earnings growth. Hospital beds, hip and knee replacements. They are geared to the aging demographic.

COMMENT
COMMENT
January 13, 2016

This is down from its highs and is a good story.

Show full opinionHide full opinion
Stryker Corp. (SYK-N)
January 13, 2016

This is down from its highs and is a good story.

PAST TOP PICK
PAST TOP PICK
November 30, 2015

(A Top Pick Jan 28/14. Up 5.15%.) Loves the company. Very innovative. They are introducing more technology in the operating room. Not only providing the product that goes into your body, but also building the robot that assists the doctor that performed the surgery. Has a great 5 year track record of increasing its dividend. Good strong balance sheet. Strong international sales. Still a Buy.

Show full opinionHide full opinion
Stryker Corp. (SYK-N)
November 30, 2015

(A Top Pick Jan 28/14. Up 5.15%.) Loves the company. Very innovative. They are introducing more technology in the operating room. Not only providing the product that goes into your body, but also building the robot that assists the doctor that performed the surgery. Has a great 5 year track record of increasing its dividend. Good strong balance sheet. Strong international sales. Still a Buy.

PAST TOP PICK
PAST TOP PICK
November 2, 2015

(A Top Pick April 7/14. Up 21.7%.) The healthcare sector is kind of fragmented into biotech, pharmaceutical and equipment. His view on the equipment side is quite constructive. Demographics are positive. Also, you don’t have the regulatory side that you have with the drugs.

Show full opinionHide full opinion
Stryker Corp. (SYK-N)
November 2, 2015

(A Top Pick April 7/14. Up 21.7%.) The healthcare sector is kind of fragmented into biotech, pharmaceutical and equipment. His view on the equipment side is quite constructive. Demographics are positive. Also, you don’t have the regulatory side that you have with the drugs.

Showing 61 to 75 of 100 entries